China National Medicines Corporation Ltd.
600511
Classifica tra le azioni
#4965
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Prezzo delle azioni
$3.89
Capitalizzazione di mercato
$2.93B
Variazione (1 giorno)
-1.72%
Variazione (1 anno)
-3.28%
Paese
CN
Scambia China National Medicines Corporation Ltd. (600511)
Categoria
Healthcare
Utile per China National Medicines Corporation Ltd. (600511)
Utile nel Jun 2026 TTM: $364.66M
Secondo gli ultimi rapporti finanziari di China National Medicines Corporation Ltd., gli utili attuali della societร sono $364.66M. Nel 2023, la societร ha registrato un utile di $414.05M, un aumento rispetto a agli utili del 2022, che erano di $389.67M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di China National Medicines Corporation Ltd. dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $364.66M | 0.30% |
| 2024 | $363.55M | -12.20% |
| 2023 | $414.05M | 6.26% |
| 2022 | $389.67M | 1.30% |
| 2021 | $384.65M | 31.06% |
| 2020 | $293.50M | -15.78% |
| 2019 | $348.48M | 18.48% |
| 2018 | $294.13M | 9.94% |
| 2017 | $267.54M | 18.23% |
| 2016 | $226.29M | 120.07% |
| 2015 | $102.83M | 1.91% |
| 2014 | $100.90M | 15.95% |
| 2013 | $87.02M | 28.00% |
| 2012 | $67.98M | 4.71% |
| 2011 | $64.92M | 26.10% |
| 2010 | $51.48M | 19.05% |
| 2009 | $43.24M | 17.69% |
| 2008 | $36.75M | 38.38% |
| 2007 | $26.56M | 79.82% |
| 2006 | $14.77M | 65.07% |
| 2005 | $8.95M | 30.75% |
| 2004 | $6.84M | 4.66% |
| 2003 | $6.54M | 21.97% |
| 2002 | $5.36M | 27.10% |
| 2001 | $4.22M | 35.00% |
| 2000 | $3.12M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $6.46B | 1,670.97% |
US
|
|
| - | - |
US
|
|
| $2.17B | 496.17% |
US
|
|
| - | - |
US
|
|
| $708.86M | 94.39% |
AU
|
